Thimble Point Acquisition Corp.
Status: Deal Closed
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $276.00M |
|---|---|
| IPO Date | Feb 2, 2021 |
| CEO | Elon S. Boms |
| Left Lead | Citigroup |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24+(3) |
| IPO Sector |
Technology
High-growth software and technology-enabled companies that are disrupting large and established industries and markets |
| IPO Geography | Global |
| Target Company | Pear Therapuetics |
| Deal Announced | Jun 22, 2021 |
| Deal Size, $M | $1,201.30M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Nov 30, 2021 |
| Amendment Vote | TBD |
| Closing Date | Dec 3, 2021 |
Formerly THMA
PEAR
PEARW
| Price | $0.00 |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Thimble Point Acquisition Corp.:
- Structure and cap table
- 11 directors & officers
- 21 filings and events
- 2 underwriters
- 9 deal advisors
- 3 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Elon S. Boms | 40 | CEO and Chairman |
| Steven J. Benson | 62 | COO and Director |
| Joseph Iannotta | 41 | CFO |
| Michael J. Christenson | 62 | Director |
| Megan M. FitzGerald | 50 | Director |
| Henry S. Miller | 75 | Director |
| Anil Aggarwal | Advisor | |
| Brian Barth | Advisor | |
| Michael K. Simon | Advisor | |
| Michael Tessler | Advisor | |
| Jarrod Yuster | Advisor |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Citigroup | Joint BR | 14,400,000 | units |
| Credit Suisse | Joint BR | 9,600,000 | |
| 24,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.